Landscape Capital Management L.L.C. Invests $5.14 Million in LifeStance Health Group, Inc. $LFST

Key Points

• Landscape Capital Management L.L.C. has acquired a new position in LifeStance Health Group, Inc., purchasing 770,994 shares valued at approximately $5.1 million, representing about 0.20% of the company's stock.
• Analysts have positive sentiments towards LifeStance, with ratings of "buy" issued by firms like BTIG Research and UBS Group, and an average target price of $8.50.
• LifeStance Health Group reported a revenue increase of 10.6% year-over-year, with quarterly earnings of ($0.01) per share, surpassing analysts' expectations.

Landscape Capital Management L.L.C. bought a new stake in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 770,994 shares of the company's stock, valued at approximately $5,135,000. Landscape Capital Management L.L.C. owned about 0.20% of LifeStance Health Group at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the business. Vanguard Group Inc. boosted its stake in shares of LifeStance Health Group by 5.0% during the first quarter. Vanguard Group Inc. now owns 11,221,237 shares of the company's stock worth $74,733,000 after buying an additional 531,841 shares during the period. Jennison Associates LLC boosted its stake in shares of LifeStance Health Group by 2.1% during the first quarter. Jennison Associates LLC now owns 8,255,236 shares of the company's stock worth $54,980,000 after buying an additional 168,856 shares during the period. Wellington Management Group LLP boosted its stake in shares of LifeStance Health Group by 2.3% during the first quarter. Wellington Management Group LLP now owns 5,399,293 shares of the company's stock worth $35,959,000 after buying an additional 123,056 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of LifeStance Health Group by 87.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company's stock worth $25,977,000 after buying an additional 1,643,390 shares during the period. Finally, Parcion Private Wealth LLC acquired a new stake in shares of LifeStance Health Group during the first quarter worth about $15,670,000. Institutional investors and hedge funds own 85.50% of the company's stock.

Insider Buying and Selling at LifeStance Health Group

In related news, insider Ujjwal Ramtekkar sold 16,000 shares of the business's stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $5.94, for a total transaction of $95,040.00. Following the completion of the sale, the insider owned 113,435 shares of the company's stock, valued at $673,803.90. This represents a 12.36% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Darren M. Black sold 8,407,643 shares of the company's stock in a transaction dated Monday, August 18th. The stock was sold at an average price of $5.07, for a total transaction of $42,626,750.01. Following the completion of the transaction, the director owned 33,524,715 shares of the company's stock, valued at approximately $169,970,305.05. This trade represents a 20.05% decrease in their position. The disclosure for this sale can be found here. Insiders sold 20,423,643 shares of company stock worth $103,561,790 in the last quarter. 6.60% of the stock is currently owned by corporate insiders.

LifeStance Health Group Price Performance

Shares of LFST remained flat at $5.48 during midday trading on Monday. 2,067,678 shares of the stock traded hands, compared to its average volume of 3,220,483. The firm has a 50 day moving average price of $4.72 and a 200 day moving average price of $5.89. The stock has a market cap of $2.13 billion, a PE ratio of -109.60 and a beta of 1.17. LifeStance Health Group, Inc. has a one year low of $3.74 and a one year high of $8.61. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.19.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.02. The company had revenue of $345.31 million during the quarter, compared to the consensus estimate of $345.05 million. LifeStance Health Group had a negative net margin of 1.23% and a negative return on equity of 1.11%. The company's revenue was up 10.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.06) EPS. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Equities analysts anticipate that LifeStance Health Group, Inc. will post -0.18 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently commented on LFST. UBS Group raised their price objective on shares of LifeStance Health Group from $8.50 to $9.00 and gave the company a "buy" rating in a research report on Friday, August 8th. BTIG Research began coverage on shares of LifeStance Health Group in a research note on Friday, July 25th. They issued a "buy" rating and a $8.00 target price for the company. Finally, Wall Street Zen upgraded shares of LifeStance Health Group from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $8.50.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.